IT1255237B - Hydrophilic pharmaceutical composition having anti- inflammatory activity - Google Patents
Hydrophilic pharmaceutical composition having anti- inflammatory activityInfo
- Publication number
- IT1255237B IT1255237B ITMI921749A ITMI921749A IT1255237B IT 1255237 B IT1255237 B IT 1255237B IT MI921749 A ITMI921749 A IT MI921749A IT MI921749 A ITMI921749 A IT MI921749A IT 1255237 B IT1255237 B IT 1255237B
- Authority
- IT
- Italy
- Prior art keywords
- pharmaceutical composition
- inflammatory activity
- hydrophilic pharmaceutical
- hydrophilic
- benzothiazine
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- RHIWTQKHSDZEAB-UHFFFAOYSA-N 2-amino-2-(2,6-dichlorophenyl)-3-phenylpropanoic acid Chemical compound ClC1=C(C(=CC=C1)Cl)C(C(=O)O)(CC1=CC=CC=C1)N RHIWTQKHSDZEAB-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A topical pharmaceutical composition in the form of a foam having anti-inflammatory activity which contains a suitable soluble salt of a compound selected from the group comprising 2-(2,6-dichlorophenyl) amino benzyl acetic acid and 4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide as active ingredient is described.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI921749A IT1255237B (en) | 1992-07-17 | 1992-07-17 | Hydrophilic pharmaceutical composition having anti- inflammatory activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI921749A IT1255237B (en) | 1992-07-17 | 1992-07-17 | Hydrophilic pharmaceutical composition having anti- inflammatory activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI921749A0 ITMI921749A0 (en) | 1992-07-17 |
| ITMI921749A1 ITMI921749A1 (en) | 1994-01-17 |
| IT1255237B true IT1255237B (en) | 1995-10-20 |
Family
ID=11363692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI921749A IT1255237B (en) | 1992-07-17 | 1992-07-17 | Hydrophilic pharmaceutical composition having anti- inflammatory activity |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1255237B (en) |
-
1992
- 1992-07-17 IT ITMI921749A patent/IT1255237B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI921749A1 (en) | 1994-01-17 |
| ITMI921749A0 (en) | 1992-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2160366A1 (en) | Risperidone pamoate | |
| IE940583L (en) | Topical antimicrobial pharmaceutical compositions | |
| CA2004598A1 (en) | Medicinal aerosol formulations | |
| CA2213989A1 (en) | External preparation for topical administration | |
| WO1999001103A3 (en) | Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition | |
| RU94041223A (en) | Agent for motoneuron disease treatment | |
| NO303734B1 (en) | Triazolylthiomethylthiocephalosporin hydrochloride, its crystalline hydrate and pharmaceutical composition containing this | |
| CA2201477A1 (en) | New pyrimidone derivatives with antifungal activity | |
| CA2282345A1 (en) | Pharmaceutical composition | |
| GR3031044T3 (en) | Pharmaceutical and/or cosmetic preparation and the use of the preparation | |
| EP0382066A3 (en) | Use of dihydroliponic acid as an analgetic, antiphlogistic and/or cytoprotective agent | |
| CA2190303A1 (en) | Pharmaceutical composition, method and device for preventing or treating dry eye or disease caused therefrom | |
| CA2284774A1 (en) | Theobromine antitussive compositions | |
| CA2161703A1 (en) | Pour-on Formulations Containing Polymeric Material, Glycols and Glycerides | |
| CA2192416A1 (en) | Crop protection products | |
| CA2141964A1 (en) | Pharmaceutical agents containing diphosphonic acids and salts thereof | |
| CA2292629A1 (en) | Composition comprising 5-¬4-¬2-(n-methyl-n-2-pyridyl)amino)ethoxy|benzyl|thiazolidine-2,4-dione | |
| CA2088994A1 (en) | Therapeutically active mixture of glutathion and anthocyan compounds | |
| EP0842663A4 (en) | Ophthalmic preparations | |
| CA2192822A1 (en) | Use of immunosuppressive agents for the treatment of schizophrenia | |
| IT1255237B (en) | Hydrophilic pharmaceutical composition having anti- inflammatory activity | |
| AU1146688A (en) | Agent having renal function-improving effect and diuretic effect | |
| EP0342423A3 (en) | Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics | |
| EP1031567A4 (en) | Thiadiazole carboxamide derivative, plant disease controlling agent, and method of using the same | |
| CA2182812A1 (en) | Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970721 |